These apparent differences between left-sided and right-sided colon cancers may be because, at the molecular level, left-sided colon cancers have better predictive markers for patients undergoing chemotherapy, such as CIN, p53, and NRAS mutations. This evidence concerns the gene NRAS and cervical squamous intraepithelial neoplasia.